Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
---|---|
Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
ClinicalTrials.gov Identifier: | NCT00119821 |
To evaluate the effectiveness of lifestyle modification following a smoking cessation program in preventing weight gain among hypertensive smokers placed at medical risk by the post-cessation weight gain.
Condition | Intervention |
---|---|
Cardiovascular Diseases Heart Diseases Hypertension Obesity |
Behavioral: Weight Reducing Diet Behavioral: Exercise Behavioral: Smoking Cessation |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Single Blind (Investigator), Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Weight Gain Prevention in Hypertensive Smokers |
Estimated Enrollment: | 660 |
Study Start Date: | September 2004 |
Estimated Study Completion Date: | September 2009 |
Estimated Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
I: Experimental
Behavioral Weight Reduction
|
Behavioral: Weight Reducing Diet
Behavioral intervention
|
II
Exercise
|
Behavioral: Exercise
Moderate exercise implemented plus behavioral intervention.
|
III
Smoking Cessation
|
Behavioral: Smoking Cessation
Nicotine Patch in dosages given based on number of cigarettes per day smoked. 21 mg patch, 14 mg patch, 7 mg patch for total of 6 weeks duration of therapy.
|
BACKGROUND:
Obesity and smoking are major risk factors for a variety of health-related disorders, such as heart disease, stroke, certain forms of cancer, and diabetes. Recently, it has been reported that up to 65 percent of adults in the United States are overweight or obese. The increasing epidemic of obesity has led to many initiatives to treat obesity and to a number of recent initiatives to prevent weight gain. Similarly, the prevalence of smoking has not declined in the past few years, despite the availablity of several clinically and cost-effective smoking cessation programs. One unwanted effect of smoking cessation is weight gain, which, in turn, may exacerbate weight-related health issues. Behavioral programs, and to a lesser degree pharmacological programs, designed to reduce post-cessation weight gain have been successful. However, given that this weight gain is typically cosmetic, it has been determined that such programs should be targeted to those at a higher medical risk as a result of the weight gain (e.g., individuals with hypertension). To our knowledge, no study has evaluated a smoking cessation program, followed by a lifestyle modification program, to prevent weight gain among those placed at medical risk by the post-cessation weight gain, including individuals with hypertension. Some studies find an increased prevalence of hypertension following smoking cessation. It is believed that this is largely (but not solely) due to weight gain following cessation. However, any weight gain in individuals with hypertension places them at risk. Body weight is the single best predictor of adult blood pressure, and blood pressure responds to very small changes in overall body weight.
DESIGN NARRATIVE:
This study will recruit 660 smokers with hypertension or elevated blood pressure. Given that African Americans are at high risk for both post-cessation weight gain and hypertension, the majority of participants recruited will be African American. Participants will be randomly assigned to either of the following: (a) a validated smoking cessation program followed by a validated weight control program (TONE), which consists of changes in dietary intake and physical activity; or (b) the same smoking cessation program followed by a general health education (contact-time control) program. A follow-up evaluation will occur 1 year following the end of treatment.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Tennessee | |
University of Tennessee Center for Health Sciences | Recruiting |
Memphis, Tennessee, United States, 38163 | |
Contact: Robert C. Klesges, PhD 507-266-1092 bob.klesges@stjude.org | |
Study Chair: Robert C. Klesges |
Study Chair: | Robert C. Klesges, PhD | University of Tennessee Center for Health Sciences |
Responsible Party: | University of Tennessee Health Science Center Department of Preventive Medicine ( Robert Klesges, PhD ) |
Study ID Numbers: | 225, R01 HL74845 |
Study First Received: | July 6, 2005 |
Last Updated: | November 12, 2008 |
ClinicalTrials.gov Identifier: | NCT00119821 |
Health Authority: | United States: Federal Government |
Nicotine polacrilex Obesity Heart Diseases Vascular Diseases Overweight Weight Gain Body Weight |
Signs and Symptoms Nicotine Body Weight Changes Nutrition Disorders Overnutrition Hypertension |
Cardiovascular Diseases |